“…Little is known about the role gene expression plays in KPC-mediated resistance or how the level of expression may affect susceptibility testing. Hydrolysis of carbapenems by KPCs has been demonstrated in vitro (1,21,22); however, multiple studies have reported variability in susceptibility testing of KPC-producing clinical isolates (2,3,13,22). Although variation in KPC enzyme production could contribute to the variability seen during susceptibility testing, it is difficult to assess the influence of the KPC -lactamase on susceptibility testing using clinical isolates which may harbor multiple -lactamases and may have alterations in outer membrane proteins (4,7,9,10,21,24).…”